Dystrophic Epidermolysis Bullosa Research Association (DEBRA) Research and the University Medical Center Groningen (UMCG), ...

Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates ...

Novartis has announced that ianalumab has received Breakthrough Therapy designation from the US FDA to treat Sjögren’s disease.

NanoSyrinx has announced the appointment of Thomas J Farrell as its new CEO.

Novo Nordisk’s Wegovy (semaglutide injection) has received a new approval from the Medicines and Healthcare products ...

The financing includes new investors Pfizer Ventures and Apricot Capital, bringing the total capital raised to $100m ...

Learn how a next-generation approach to field training – powered by Generative AI (GenAI) and lifelike avatar simulations and ...

For decades, pharma communications spoke the language of health systems, designed to inform healthcare professionals, ...

The terms of the agreement state that AbbVie will provide lower-priced prescription drugs through the Medicaid programme. It ...

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, ...

Takeda’s zasocitinib has shown strong rates of skin clearance, as well as other benefits, in new study results regarding ...

Colorectal cancer is the third most common cancer globally, with approximately 1.8 million people diagnosed in 2022 ...